Clinical Trial Update: Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of sorafenib in combination with carboplatin and paclitaxel for metastatic or recurrent head and neck squam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Sorafenib (Nexavar) (Sorafenib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx | Phase 2 | Status: ACTIVE_NOT_RECRUITING